Author

Margaret M. Reuter

University of MichiganORCID 0000-0001-9329-6944Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Approach:machine learning (classical)· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Aaron M. RobidaiD· 1 shared David H. ShermaniD· 1 shared Debmalya Sarkar· 1 shared Harkirat Singh AroraiD· 1 shared Jon Albo· 1 shared Katherine L. LeviD· 1 shared Madeline R. ShayiD· 1 shared Nate CiraiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Aaron M. RobidaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Systems BiologybioRxivPreprintNov 25, 2024

Ultra-high-throughput screening of antimicrobial combination therapies using a two-stage transparent machine learning model

Margaret M. Reuter, Katherine L. Lev, Jon Albo…·Sriram Chandrasekaran

This paper introduces M2D2, a two-stage ML model that identifies synergistic antimicrobial drug combinations and validates them experimentally against E. coli.

7 citations

E. colimetabolomics

𝕏 PostBluesky